Vivo Opportunity Fund Holdings, L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for Unicycive Therapeutics, Inc. Common Stock, $0.001 par value per share (UNCY)

Filing Manager: Vivo Opportunity Fund Holdings, L.P.
Reporting Manager: Vivo Opportunity Fund Holdings, L.P.
Security: Unicycive Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol: UNCY
Shares outstanding: 61,022,773 shares
Disclosed Ownership: 6,096,175 shares
Ownership: 10%
Form type: SCHEDULE 13G/A
Filing time: 14 Nov 2025, 18:34:02 UTC
Date of event: 30 Sep 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Vivo Opportunity Fund Holdings, L.P.	10%	6,096,175	6,096,175	0	/s/ Kevin Dai	Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner
Vivo Opportunity, LLC	10%	6,096,175	6,096,175	0	/s/ Kevin Dai	Kevin Dai/Managing Member